Sentinel lymph node biopsy in breast cancer patients: subdermal versus peritumoural radiocolloid injection

Nuclear Medicine Communications

Volumn 22, Issue 1, 2001, Pages 17-24

  MATEOS, J J ^a   VIDAL SICART, S ^b   ZANÓN, G ^b   PAHISA, J ^b   FUSTER, D ^b   MARTÍN, F ^b   ORTEGA, M ^b   FERNÁNDEZ, P ^b   PONS, F ^b  

^a Nuclear Medicine Gynaecology   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Breast cancer; Gamma probe detection; Lymphoscintigraphy; Peritumoural injection; Subdermal injection

Indexed keywords

LYMPHOSCINT; RADIOISOTOPE; TECHNETIUM 99M;

ARTICLE; BREAST CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; FEMALE; GAMMA RADIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SCINTIMAMMOGRAPHY; SENTINEL LYMPH NODE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INJECTIONS; INJECTIONS, SUBCUTANEOUS; LYMPH NODES; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 0035111374     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200101000-00003     Document Type: Article

References (23)

1. Krag D, Weaver D, Ashikaga T et al. The sentinel node in breast cancer. A multicenter validation. New Engl J Med 1998; 339: 941-946.
2. Keshtgar MRS, Ell PJ. Sentinel lymph node detection and imaging. Eur J Nucl Med 1999; 26: 57-67.
3. Morton DL, Wen D, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
4. Kapteijn BAE, Nieweg OE, Muller SH et al. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 1997; 38: 362-366.
5. Vidal-Sicart S, Piulachs J, Pons F et al. Detection of sentinel lymph nodes by gammagraphy and intraoperative gamma-ray probe in patients with malignant melanoma. Initial results. Rev Esp Med Nucl 1998; 17: 15-20.
6. Kapteijn BAE, Nieweg OE, Peterse JL et al. Identification and biopsy of the sentinel node in breast cancer. Eur J Surg Oncol 1998; 24: 427-430.
7. Cabanas RM. An approach to the treatment of penile carcinoma. Cancer 1977; 39: 456-466.
8. De Hullu JA, Doting E, Piers DA et al. Sentinel lymph node identification with technetium-99m-labelled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998; 39: 1381-1385.
9. Nieweg OE, Jansen I, Valdés Olmos RA et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999; 26(Suppl.): 11-16.
10. Alazraki NP, Eshima D, Eshima LA et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997; 27: 55-67.
11. Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
12. Uren RF, Howman-Giles RB, Thompson JF et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-1780.
13. Pijpers R, Meijer S, Hoekstra OS et al. Impact of lymphoscintigraphy on sentinel-node identification wih technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366-368.
14. O'Hea BJ, Hill ADK, El-Shirbiny AM et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-427.
15. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23: 495-502.
16. Borgstein PJ, Pijpers R, Comans EF, Van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guide-lines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
17. Van Der Wall . The sentinel node in breast cancer. Implications for adjuvant treatment. Eur J Nucl Med 1999; 26(Suppl.): 17-19.
18. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathological validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-278.
19. Albertini JJ, Lyman GH, Cox C et al. Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. J Am Med Assoc 1996; 276: 1818-1822.
20. Uren RF, Howman-Giles RB, Thompson JF. The value of preoperative lymphoscintigraphy in breast cancer treatment. Eur J Cancer 1998; 34: 203-204.
21. Turner-Warwick RT. The lymphatics of breast. Br J Surg 1957; 46: 574-582.
22. Gulec SA, Moffat FL, Carrol RG. The expanding clinical role for intraoperative gamma probes. In: Freeman LM, ed. Nuclear Medicine Annual 1997. Philadelphia: Lippincott-Raven, 1997: 209-237.
23. Gill PG, Hall VE, Kirkwood I et al. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer. (Abstract) Breast 1997; 6: 225.